Newsroom | 98184 results

Casablanca, Maroc – Lugano, Suisse--(BUSINESS WIRE)--Le Groupe Laprophan, l’un des principaux groupes pharmaceutiques pionniers au Maroc, a annoncé aujourd’hui l’acquisition finale réussie d’une participation majoritaire dans Rivopharm, une société pharmaceutique basée en Suisse spécialisée dans les médicaments de spécialité, le développement de dossiers réglementaires, les formulations complexes et les solutions pharmaceutiques à valeur ajoutée, et disposant de son propre site de production in...

PALO ALTO, Calif.--(BUSINESS WIRE)--Spot Biosystems launches with $40M financing and world-first non-viral delivery of full-length dystrophin in animal models and human patients with DMD...

NEW YORK--(BUSINESS WIRE)--Clear Health, a telehealth platform for personalized, at-home skincare, launches Isoclear™, the first prescription topical acne treatment built around isotretinoin - the same active ingredient used in oral Accutane - delivered through a multi-phase regimen. Isoclear takes one of dermatology’s most well-known molecules and reimagines it in a topical format, combining clinically proven ingredients into customized, prescription formulations delivered through a digital-fi...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Independent Pharmacy Cooperative (IPC), and pharmacy-tech platform Nimble, a Swoop Company, today announced a strategic partnership aimed at providing innovation to pharmacies and patients through tech-enabled services. Through the partnership, IPC members gain access to digital tools that simplify pharmacy workflows, improve patient communication, and deliver care without sacrificing personalized service communities rely on — all at no cost. The collabora...

AUSTIN, Texas--(BUSINESS WIRE)--Rugiet, the performance medicine company that’s helped more than 500,000 men take control of their health, today announced the expansion of its treatment areas to include longevity. Rugiet is bringing its physician-prescribed standards to an emerging wellness category dominated by unregulated sources with limited medical oversight. NAD+, Glutathione, Lipo-C, L-Carnitine, and Sermorelin are now available to Rugiet patients as prescribed compounds dispensed by a 50...

BRISTOL, Wis.--(BUSINESS WIRE)--The rapid growth of adherence packaging, driven by chronic care programs, LTC At Home, and patient demand for home-based improved daily management, has exposed a critical operational gap. Many pharmacies still rely on labor-intensive manual methods for blister cards and prescription vials, increasing the risk of filling errors, consuming valuable pharmacist check time, and limiting growth opportunities in emerging markets. To address this challenge, JFCRx, a lead...

CASABLANCA, Morocco & LUGANO, Switzerland--(BUSINESS WIRE)--Laprophan completes the acquisition of Rivopharm, accelerating its international expansion strategy...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Bortezomib for Injection in the United States. The product contains the same active ingredient as VELCADE®, as approved by the U.S. Food and Drug Administration, and is indicated for the treatment of adults with multiple myeloma and mantle cell lymphoma. Bortezomib for Injection is available as a carton of one 3.5 mg single-dose via...

NASHVILLE, Tenn.--(BUSINESS WIRE)--PhaseWell Research (“PhaseWell”), a multisite clinical research company, today announced its partnership with Latin Clinical Trial Center (“LCTC”) in San Juan, Puerto Rico. Led by founder and Principal Investigator Dr. Carlos A. Sariol and Site Leader Anmari Ferrer, LCTC is widely recognized as one of Puerto Rico’s foremost clinical research sites, with two decades of continuous operation and a track record spanning more than 85 clinical studies across Phase I...

SINGAPORE & SAN FRANCISCO--(BUSINESS WIRE)--Gero secures $17M in new financing, bringing total funding to $34M to advance AI-driven drug discovery for aging and chronic diseases....